What is NAD+?
NAD+ (nicotinamide adenine dinucleotide) is technically a coenzyme rather than a peptide, but is widely grouped with the longevity protocols studied in peptide research communities. Injectable NAD+ and its precursors (NR, NMN) have been studied for sirtuin activation, mitochondrial function, and age-related metabolic decline.
Mechanism of action
NAD+ is a substrate for sirtuins (SIRT1–7), PARP enzymes (DNA repair), and CD38 (NAD+ degradation). Cellular NAD+ levels decline with age, and restoration has been associated with improved mitochondrial function, DNA repair, and inflammatory markers.
Researched benefits
- Improved mitochondrial function in aged tissues
- Sirtuin pathway activation
- DNA repair and genomic stability support
- Improved cognitive and metabolic markers in pilot work
Researched dosage
Most research protocols use 50000–250000 mcg administered 1× per day via subcutaneous injection. Subcutaneous research protocols commonly use 50–250 mg daily. Higher IV doses (250–750 mg) are studied in clinic settings under supervision.
A typical cycle runs 4 weeks on, then 2 weeks off before reassessment.
Use the calculator below to convert your target NAD+ dose into exact insulin-syringe units.
Reconstitution & storage
A standard 500 mg vial reconstituted with 5 mL of bacteriostatic water yields 100000 mcg/mL. Lyophilized stable at 2–8°C. Refrigerate post-reconstitution and protect from light.
Side effects & considerations
- Flushing, nausea, chest tightness during fast administration
- Headache
- Injection-site irritation with subcutaneous use
NAD+ stacks
- Cellular Longevity — paired with Epitalon. Layered mitochondrial and telomere research. Investigators sometimes pair NAD+ restoration with Epitalon for mitochondrial-plus-telomere longevity modeling.
Selected research
- NAD+ in aging, metabolism, and neurodegeneration — Science, 2015
- NAD+ precursor supplementation and human metabolism — Cell Metabolism, 2018